10 at 10: These ASX stocks are galvanizing support this morning

Bolivian presidential candidate of MAS (Movimiento al Socialismo) Luis Arce gives a speech during his closing rally ahead of this week's Presidential elections (Pic: Getty)

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code	Company	Price	%	Volume
TIG	Tigers Realm Coal	0.029	314	1862520
PCL	Pancontinental Oil	0.002	100	250000
UUV	UUV Aquabotix Ltd	0.002	100	500000
PM1	Pure Minerals Ltd	0.047	57	44988313
ALT	Analytica Limited	0.003	50	100000
ANW	Aus Tin Mining	0.0015	50	384000
APG	Austpac Resources NL	0.003	50	2100000
CLZ	Classic Min Ltd	0.002	33	2500000
FPL	Fremont Petroleum	0.004	33	2600000
RBL	Redbubble Limited	5.63	17	1304164

Russia-focused coal play Tigers Realm (ASX:TIG) signed a supply contract to build a coal handling and preparation plant and has more than quadrupled this morning.

Pure Minerals (ASX:PM1) rose after unveiling an offtake agreement with South Korean chemicals giant LG Chem for Pure Minerals’ nickel and cobalt project in Queensland.

Independent artist-focused ecommerce company Redbubble (ASX:RBL) surged again with its latest trading update.

Code	Company	Price	%	Volume
CCE	Carnegie Cln Energy	0.001	-33	1345000
NWE	Norwest Energy NL	0.003	-25	84000
PSL	Paterson Resources	0.003	-25	1520000
ACW	Actinogen Medical	0.023	-18	5963663
AGE	Alligator Energy	0.005	-17	1900000
NTL	New Talisman Gold	0.005	-17	330000
TYX	Tyranna Res Ltd	0.005	-17	281396
CZN	Corazon Ltd	0.003	-14	3110000
NPM	Newpeak Metals	0.003	-14	900000
WKT	Walkabout Resources	0.195	-9	22500

Biotech stock Actinogen (ASX:ACW), which is one of the few ASX stocks tackling dementia, fell after completing a capital raising to fund new clinical trials.